Amgen (AMGN) Non-Current Debt (2009 - 2026)
Amgen's quarterly Non-Current Debt came in at $51.9 billion in Q1 2026, down 3.94% year-on-year from $54.0 billion in Q1 2025, and up 3.76% quarter-over-quarter from $50.0 billion in Q4 2025.
Amgen has reported Non-Current Debt for 18 years, with the latest figure at $51.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt fell 3.94% year-over-year to $51.9 billion; the trailing twelve-month figure through Mar 2026 stood at $51.9 billion (down 3.94% YoY), and the FY2025 full-year result was $50.0 billion, down 11.57% from the prior year.
- Non-Current Debt for Q1 2026 stood at $51.9 billion, up from $50.0 billion in the prior quarter.
- The five-year high for Non-Current Debt was $63.2 billion in Q4 2023, with the low at $35.7 billion in Q2 2022.
- Average Non-Current Debt over 5 years is $51.8 billion, with a median of $54.0 billion recorded in 2025.
- Year-over-year, Non-Current Debt soared 69.11% in 2023 and declined 11.57% in 2025.
- Tracing AMGN's Non-Current Debt over 5 years: stood at $37.4 billion in 2022, then soared by 69.11% to $63.2 billion in 2023, then dropped by 10.48% to $56.5 billion in 2024, then fell by 11.57% to $50.0 billion in 2025, then climbed by 3.76% to $51.9 billion in 2026.
- The last three Non-Current Debt figures came in at $51.9 billion (Q1 2026), $50.0 billion (Q4 2025), and $52.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 39.37 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 37.53 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 64.53 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 46.67 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 51.89 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 20.86 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 60.57 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 42.15 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 19.55 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.89 Bn |
| Mar 31, 2026 | 51.89 Bn |
| Dec 31, 2025 | 50.01 Bn |
| Dec 31, 2025 | 50.01 Bn |
| Sep 30, 2025 | 52.43 Bn |
| Sep 30, 2025 | 52.43 Bn |
| Jun 30, 2025 | 53.76 Bn |
| Jun 30, 2025 | 53.76 Bn |
| Mar 31, 2025 | 54.01 Bn |
| Mar 31, 2025 | 54.01 Bn |
| Dec 31, 2024 | 56.55 Bn |
| Dec 31, 2024 | 56.55 Bn |
| Sep 30, 2024 | 56.85 Bn |
| Sep 30, 2024 | 56.85 Bn |
| Jun 30, 2024 | 57.12 Bn |
| Jun 30, 2024 | 57.12 Bn |
| Mar 31, 2024 | 60.06 Bn |
| Mar 31, 2024 | 60.06 Bn |
| Dec 31, 2023 | 63.17 Bn |
| Dec 31, 2023 | 63.17 Bn |
| Sep 30, 2023 | 59.04 Bn |
| Sep 30, 2023 | 59.04 Bn |
| Jun 30, 2023 | 59.38 Bn |
| Jun 30, 2023 | 59.38 Bn |
| Mar 31, 2023 | 60.76 Bn |
| Mar 31, 2023 | 60.76 Bn |
| Dec 31, 2022 | 37.35 Bn |
| Dec 31, 2022 | 37.35 Bn |
| Sep 30, 2022 | 37.16 Bn |
| Sep 30, 2022 | 37.16 Bn |
| Jun 30, 2022 | 35.71 Bn |
| Jun 30, 2022 | 35.71 Bn |
| Mar 31, 2022 | 36.01 Bn |
| Mar 31, 2022 | 36.01 Bn |
| Dec 31, 2021 | 33.22 Bn |
| Dec 31, 2021 | 33.22 Bn |
| Sep 30, 2021 | 33.29 Bn |
| Sep 30, 2021 | 33.29 Bn |
| Jun 30, 2021 | 28.46 Bn |
| Jun 30, 2021 | 28.46 Bn |
| Mar 31, 2021 | 31.13 Bn |
| Mar 31, 2021 | 31.13 Bn |
| Dec 31, 2020 | 32.90 Bn |
| Dec 31, 2020 | 32.90 Bn |
| Sep 30, 2020 | 34.20 Bn |
| Sep 30, 2020 | 34.20 Bn |
| Jun 30, 2020 | 34.13 Bn |
| Jun 30, 2020 | 34.13 Bn |
| Mar 31, 2020 | 30.01 Bn |
| Mar 31, 2020 | 30.01 Bn |
| Dec 31, 2019 | 26.95 Bn |
| Dec 31, 2019 | 26.95 Bn |
| Sep 30, 2019 | 27.74 Bn |
| Sep 30, 2019 | 27.74 Bn |
| Jun 30, 2019 | 27.80 Bn |
| Jun 30, 2019 | 27.80 Bn |
| Mar 31, 2019 | 29.32 Bn |
| Mar 31, 2019 | 29.32 Bn |
| Dec 31, 2018 | 29.51 Bn |
| Dec 31, 2018 | 29.51 Bn |
| Sep 30, 2018 | 29.35 Bn |
| Sep 30, 2018 | 29.35 Bn |
| Jun 30, 2018 | 30.21 Bn |
| Jun 30, 2018 | 30.21 Bn |
| Mar 31, 2018 | 33.36 Bn |
| Mar 31, 2018 | 33.36 Bn |
| Dec 31, 2017 | 34.19 Bn |
| Dec 31, 2017 | 34.19 Bn |
| Sep 30, 2017 | 33.78 Bn |
| Sep 30, 2017 | 33.78 Bn |
| Jun 30, 2017 | 33.60 Bn |
| Jun 30, 2017 | 33.60 Bn |
| Mar 31, 2017 | 30.29 Bn |
| Mar 31, 2017 | 30.29 Bn |
| Dec 31, 2016 | 30.19 Bn |
| Dec 31, 2016 | 30.19 Bn |
| Sep 30, 2016 | 30.53 Bn |
| Sep 30, 2016 | 30.53 Bn |
| Jun 30, 2016 | 27.93 Bn |
| Jun 30, 2016 | 27.93 Bn |
| Mar 31, 2016 | 32.06 Bn |
| Mar 31, 2016 | 32.06 Bn |
| Dec 31, 2015 | 29.18 Bn |
| Dec 31, 2015 | 29.18 Bn |
| Sep 30, 2015 | 30.51 Bn |
| Sep 30, 2015 | 30.51 Bn |
| Jun 30, 2015 | 30.70 Bn |
| Jun 30, 2015 | 30.70 Bn |
| Mar 31, 2015 | 29.84 Bn |
| Mar 31, 2015 | 29.84 Bn |
| Dec 31, 2014 | 30.22 Bn |
| Dec 31, 2014 | 30.22 Bn |
| Sep 30, 2014 | 30.48 Bn |
| Sep 30, 2014 | 30.48 Bn |
| Jun 30, 2014 | 30.83 Bn |
| Jun 30, 2014 | 30.83 Bn |
| Mar 31, 2014 | 29.52 Bn |
| Mar 31, 2014 | 29.52 Bn |
| Dec 31, 2013 | 29.62 Bn |
| Dec 31, 2013 | 29.62 Bn |
| Sep 30, 2013 | 27.18 Bn |
| Sep 30, 2013 | 27.18 Bn |
| Jun 30, 2013 | 23.91 Bn |
| Jun 30, 2013 | 23.91 Bn |
| Mar 31, 2013 | 23.89 Bn |
| Mar 31, 2013 | 23.89 Bn |
| Dec 31, 2012 | 24.03 Bn |
| Dec 31, 2012 | 24.03 Bn |
| Sep 30, 2012 | 24.02 Bn |
| Sep 30, 2012 | 24.02 Bn |
| Dec 31, 2011 | 21.34 Bn |
| Dec 31, 2011 | 21.34 Bn |
| Mar 31, 2010 | 7.09 Bn |
| Mar 31, 2010 | 7.09 Bn |
| Dec 31, 2009 | 6.09 Bn |
| Dec 31, 2009 | 6.09 Bn |
| Sep 30, 2009 | 6.09 Bn |
| Sep 30, 2009 | 6.09 Bn |
| Jun 30, 2009 | 6.09 Bn |
| Jun 30, 2009 | 6.09 Bn |